NASDAQ:PMD Psychemedics (PMD) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free PMD Stock Alerts $2.55 0.00 (0.00%) (As of 11:23 AM ET) Add Compare Share Share Today's Range$2.53▼$2.6750-Day Range$2.54▼$3.1852-Week Range$2.06▼$5.59Volume1,717 shsAverage Volume10,964 shsMarket Capitalization$14.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Psychemedics alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Psychemedics Stock (NASDAQ:PMD)Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Dallas, Texas.Read More PMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PMD Stock News HeadlinesApril 25, 2024 | finance.yahoo.comPsychemedics Corporation (PMD) Stock Price, News, Quote & History - Yahoo FinanceMarch 28, 2024 | investorplace.comPMD Stock Earnings: Psychemedics Reported Results for Q4 2023April 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” March 28, 2024 | globenewswire.comPsychemedics Corporation Reports 2023 Financial ResultsMarch 21, 2024 | globenewswire.comPsychemedics Recognized as a Top 10 Employee Health Testing Services ProviderJanuary 3, 2024 | bizjournals.comSmall cap drug testing company relocates HQ to DFW from MassachusettsJanuary 2, 2024 | msn.comMassachusetts drug testing firm targeting fentanyl relocates corporate HQ to DallasJanuary 2, 2024 | markets.businessinsider.comPsychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasApril 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” November 10, 2023 | msn.comPsychemedics reports Q3 resultsNovember 9, 2023 | finance.yahoo.comPsychemedics Corporation Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | morningstar.comPsychemedics Corp PMDOctober 27, 2023 | finance.yahoo.comUnveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenSeptember 26, 2023 | benzinga.comPsychemedics Chief Revenue Officer Awarded $448K Worth of Stock OptionsSeptember 22, 2023 | benzinga.comPsychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerSeptember 21, 2023 | msn.comDo You Get PMS? You Could Be Headed for Early Menopause, Study ShowsAugust 22, 2023 | benzinga.comPresident & CEO at Psychemedics Acquires Company Stock Options Worth 300,000 SharesAugust 18, 2023 | finance.yahoo.comPsychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2023 | marketwatch.comPsychemedics 2Q Loss Widens Amid Labor Shortage, SettlementAugust 11, 2023 | marketwatch.comPsychemedics Eliminates DividendAugust 11, 2023 | finance.yahoo.comPsychemedics Corporation Reports Second Quarter 2023 Financial ResultsJuly 12, 2023 | marketwatch.comPsychemedics Taps Brian Hullinger as Successor of Long-Time CEO Ray KubackiJuly 12, 2023 | finance.yahoo.comPsychemedics Corporation Announces CEO Succession PlanMay 19, 2023 | msn.comPsychemedics's Ex-Dividend Date Is Wednesday, Here's What You Need To KnowMay 19, 2023 | finance.yahoo.comDo These 3 Checks Before Buying Psychemedics Corporation (NASDAQ:PMD) For Its Upcoming DividendMay 13, 2023 | finance.yahoo.comPsychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07May 12, 2023 | msn.comPsychemedics (PMD) Declares $0.07 DividendSee More Headlines Receive PMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/29/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:PMD CUSIPN/A CIK806517 Webwww.psychemedics.com Phone(978) 206-8220Fax978-264-9236Employees116Year Founded1985Profitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,150,000.00 Net Margins-18.39% Pretax Margin-15.56% Return on Equity-48.68% Return on Assets-26.77% Debt Debt-to-Equity RatioN/A Current Ratio1.45 Quick Ratio1.45 Sales & Book Value Annual Sales$22.10 million Price / Sales0.67 Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book2.22Miscellaneous Outstanding Shares5,806,000Free Float4,413,000Market Cap$14.81 million OptionableNot Optionable Beta0.64 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Brian Hullinger (Age 56)President, CEO & Director Comp: $361.37kMs. Daniella Mehalik (Age 34)Vice President of Finance Comp: $126.41kMs. Shannon ShoemakerChief Revenue OfficerDr. Werner A. Baumgartner Ph.D.FounderMs. Annette BaumgartnerFounderMr. Michael Weisenhoff (Age 34)Principal Financial & Accounting Manager Mr. Patrick J. Kinney Jr.SecretaryMore ExecutivesKey CompetitorsCentogeneNASDAQ:CNTGBioNexus Gene LabNASDAQ:BGLCDermTechNASDAQ:DMTKOpGenNASDAQ:OPGNExagenNASDAQ:XGNView All CompetitorsInsidersCharles M DoucotSold 12,700 sharesTotal: $59,182.00 ($4.66/share)View All Insider Transactions PMD Stock Analysis - Frequently Asked Questions How have PMD shares performed in 2024? Psychemedics' stock was trading at $2.96 at the beginning of the year. Since then, PMD stock has decreased by 13.9% and is now trading at $2.55. View the best growth stocks for 2024 here. When is Psychemedics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our PMD earnings forecast. How were Psychemedics' earnings last quarter? Psychemedics Co. (NASDAQ:PMD) issued its quarterly earnings results on Thursday, March, 28th. The company reported ($0.16) earnings per share (EPS) for the quarter. The firm earned $5 million during the quarter. Psychemedics had a negative trailing twelve-month return on equity of 48.68% and a negative net margin of 18.39%. How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics? Psychemedics announced a quarterly dividend on Tuesday, May 9th. Shareholders of record on Thursday, May 25th will be paid a dividend of $0.07 per share on Thursday, June 8th. This represents a $0.28 dividend on an annualized basis and a yield of 10.98%. The ex-dividend date of this dividend is Wednesday, May 24th. Read our dividend analysis for PMD. Is Psychemedics a good dividend stock? Psychemedics (NASDAQ:PMD) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for PMD. What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO? 6 employees have rated Psychemedics Chief Executive Officer Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among the company's employees. What other stocks do shareholders of Psychemedics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG). How do I buy shares of Psychemedics? Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PMD) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psychemedics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
